Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Viral Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1480041

Circulating mucosal-like IgA responses associate increase with severity of Puumala orthohantavirus-caused hemorrhagic fever with renal syndrome

Provisionally accepted
  • 1 Faculty of Medicine, University of Helsinki, Helsinki, Uusimaa, Finland
  • 2 University of Tampere, Tampere, Pirkanmaa, Finland

The final, formatted version of the article will be published soon.

    Old World Orthohantaviruses cause hemorhagic fever with renal syndrome (HFRS) characterized by increased vascular permeability and acute kidney injury (AKI). Despite the systemic nature of the disease, the virus enters humans through inhalation and therefore initially encounters the immunoglobulin class A (IgA) dominated mucosal immune system. Herein, we characterized systemic IgA responses and their potential relationship to the mucosal immune activation by examining blood samples obtained from patients hospitalized due to acute Puumala orthohantavirus infection. Our findings reveal increased frequencies of putative IgA-expressing circulating mucosalassociated B1 cells and plasmablasts, as well as elevated levels of polyreactive, polymeric, virusspecific and secretory IgA in the acute stage of the disease. Importantly, the levels of circulating virus-specific and secretory IgA, as well as the putative IgA+ B1 cells, associated increased with the severity of AKI. Furthermore, circulating polymeric IgA displayed enhanced effector functions by forming stable complexes with the IgA receptor CD89 and induced pro-inflammatory neutrophil responses. These results suggest that excessive levels of circulating mucosal-like IgA might serve as a biomarker for HFRS disease progression.These results suggest that, while an efficient mucosal immune response is likely to be crucial for infection clearance, an excessive mucosal immune activation may contribute to HFRS disease progression.

    Keywords: HFRS, Hantavirus, IgA, mucosal immunity, Neutrophils

    Received: 13 Aug 2024; Accepted: 08 Oct 2024.

    Copyright: © 2024 Cabrera, Buckner, Then, Maki, Vapalahti, Vaheri, Hepojoki, Tietavainen, Makela, Mustonen and Strandin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tomas Strandin, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Uusimaa, Finland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.